Dr. Steven Fakharzadeh, MD, PhDGlobal Medical Affairs Leader Immunodermatology at JanssenSpeaker
Agenda Sessions
Program Update on JNJ-2113, The First and Only Investigational Targeted Oral Peptide for Psoriasis
, 1:45pmView Session